Xiao-Mei Qi

Dr. Xiao-Mei Qi is an Associate Professor in the Department of Pharmacology and Toxicology at the Medical College of Wisconsin. Her research focuses on cancer biology, particularly the role of nuclear receptors (e.g., Vitamin D Receptor and Estrogen Receptor) in stress response and therapeutic resistance. She investigates signaling pathways such as MAPK cascades and their impact on cancer progression and treatment strategies.

Dr. Qi holds an MD from Bengbu Medical College (1982). Her work emphasizes translational research, aiming to uncover novel therapeutic targets for cancers like colon and breast cancer. She collaborates extensively on studies involving stress-induced cell death pathways and oncogenic kinase networks.

Key research highlights include identifying the dual roles of nuclear receptors in ligand-mediated transcription and stress-regulated survival pathways, as well as the role of p38γ MAPK in inflammation-driven tumorigenesis. Her publications span over two decades, with recent contributions on kinase/phosphatase signaling and cancer stem cell expansion in triple-negative breast cancer.

Dr. Qi supervises postdoctoral and graduate students in experimental methodologies, fostering collaborative research environments. Her work has implications for developing targeted therapies to enhance cancer treatment efficacy.